New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 26, 2017 – GlaxoSmithKline (GSK) announced the discontinuation of Tanzeum (albiglutide) injection due to limited prescribing of the medicine.
Download PDF
Return to publications
